Back to mobile site

Bristol-Myers Squibb Co. (BMY) PT Lowered to $53 at Cantor Fitzgerald on Anticipated Milvexian Pressure

October 8, 2026 7:12 AM EDT Send to a Friend
Cantor Fitzgerald analyst Carter Gould lowered the price target on Bristol-Myers Squibb Co ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login